ArticlebioRxiv : the preprint server for biology2025
The extra-terminal domain drives the role of BET proteins in transcription.
Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
5 authors.
Funding
Abstract
BET proteins facilitate transcription of most eukaryotic genes but the specific mechanisms by which BET proteins perform their functions remain poorly understood. As chromatin readers, BET proteins use their tandem bromodomains to interact with acetylated lysine residues on histones and other protein partners. However, recent findings illustrate that bromodomain activity does not fully explain BET protein roles in transcription, highlighting the significance of other BET protein domains. We evaluated the importance of all conserved domains of BET proteins and determined that the extra-terminal (ET) domain is essential for cell viability, genome-wide transcription and BET protein chromatin occupancy. Furthermore, we provide evidence that the ET domain performs these functions serving as a hub for interactions with other factors involved in transcription regulation. Our findings expand current understanding of the complex biology of BET proteins and suggest the mechanisms by which cells can bypass bromodomain inhibition in pathologic states.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.